IRIS Accounts Production v26.1.10.61 07526846 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh075268462025-03-31075268462026-03-31075268462025-04-012026-03-31075268462024-03-31075268462024-04-012025-03-31075268462025-03-3107526846ns15:EnglandWales2025-04-012026-03-3107526846ns14:PoundSterling2025-04-012026-03-3107526846ns10:Director12025-04-012026-03-3107526846ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3107526846ns10:SmallEntities2025-04-012026-03-3107526846ns10:AuditExemptWithAccountantsReport2025-04-012026-03-3107526846ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3107526846ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3107526846ns10:FullAccounts2025-04-012026-03-3107526846ns10:Director22025-04-012026-03-3107526846ns10:RegisteredOffice2025-04-012026-03-3107526846ns5:CurrentFinancialInstruments2026-03-3107526846ns5:CurrentFinancialInstruments2025-03-3107526846ns5:Non-currentFinancialInstruments2026-03-3107526846ns5:Non-currentFinancialInstruments2025-03-3107526846ns5:ShareCapital2026-03-3107526846ns5:ShareCapital2025-03-3107526846ns5:RetainedEarningsAccumulatedLosses2026-03-3107526846ns5:RetainedEarningsAccumulatedLosses2025-03-310752684612025-04-012026-03-3107526846ns5:LandBuildings2025-03-3107526846ns5:PlantMachinery2025-03-3107526846ns5:FurnitureFittings2025-03-3107526846ns5:LandBuildings2025-04-012026-03-3107526846ns5:PlantMachinery2025-04-012026-03-3107526846ns5:FurnitureFittings2025-04-012026-03-3107526846ns5:LandBuildings2026-03-3107526846ns5:PlantMachinery2026-03-3107526846ns5:FurnitureFittings2026-03-3107526846ns5:LandBuildings2025-03-3107526846ns5:PlantMachinery2025-03-3107526846ns5:FurnitureFittings2025-03-3107526846ns5:MotorVehicles2025-03-3107526846ns5:ComputerEquipment2025-03-3107526846ns5:MotorVehicles2025-04-012026-03-3107526846ns5:ComputerEquipment2025-04-012026-03-3107526846ns5:MotorVehicles2026-03-3107526846ns5:ComputerEquipment2026-03-3107526846ns5:MotorVehicles2025-03-3107526846ns5:ComputerEquipment2025-03-3107526846ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3107526846ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31075268462ns10:Director22025-03-31075268462ns10:Director22024-03-31075268462ns10:Director22025-04-012026-03-31075268462ns10:Director22024-04-012025-03-31075268462ns10:Director22026-03-31075268462ns10:Director22025-03-3107526846ns10:Director112025-03-3107526846ns10:Director112024-03-3107526846ns10:Director112025-04-012026-03-3107526846ns10:Director112024-04-012025-03-3107526846ns10:Director112026-03-3107526846ns10:Director112025-03-31
REGISTERED NUMBER: 07526846 (England and Wales)














FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2026

FOR

BERKSHIRE BREAST SURGERY LIMITED

BERKSHIRE BREAST SURGERY LIMITED (REGISTERED NUMBER: 07526846)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 8

BERKSHIRE BREAST SURGERY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2026







DIRECTORS: Dr L K Smith
Mr B M Smith





REGISTERED OFFICE: 11 Warwick Road
Old Trafford
Stretford
Manchester
M16 0QQ





REGISTERED NUMBER: 07526846 (England and Wales)





ACCOUNTANTS: Dunhams
Chartered Accountants
11 Warwick Road
Old Trafford
Stretford
Manchester
M16 0QQ

BERKSHIRE BREAST SURGERY LIMITED (REGISTERED NUMBER: 07526846)

BALANCE SHEET
31 MARCH 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 504,284 519,849

CURRENT ASSETS
Debtors 5 173,435 163,160
Cash at bank 451,679 433,647
625,114 596,807
CREDITORS
Amounts falling due within one year 6 40,007 43,229
NET CURRENT ASSETS 585,107 553,578
TOTAL ASSETS LESS CURRENT LIABILITIES 1,089,391 1,073,427

CREDITORS
Amounts falling due after more than one
year

7

-

(1,186

)

PROVISIONS FOR LIABILITIES (12,340 ) (16,231 )
NET ASSETS 1,077,051 1,056,010

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 1,076,851 1,055,810
SHAREHOLDERS' FUNDS 1,077,051 1,056,010

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BERKSHIRE BREAST SURGERY LIMITED (REGISTERED NUMBER: 07526846)

BALANCE SHEET - continued
31 MARCH 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 5 August 2026 and were signed on its behalf by:





Mr B M Smith - Director


BERKSHIRE BREAST SURGERY LIMITED (REGISTERED NUMBER: 07526846)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1. STATUTORY INFORMATION

Berkshire Breast Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates
In the application of the Company's accounting policies, which are described in note 1, management is required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.

Critical accounting judgements and key sources of estimation uncertainty
The director, in preparing the accounts, does not believe that any of the judgements or estimates made would be deemed significant.

Turnover
Revenue is measured at the fair value of the consideration received or receivable and represents the amount receivable for services rendered net of value added taxes.

Tangible fixed assets
Tangible assets are stated at cost (or deemed cost) less accumulated depreciation and accumulated impairment losses. Cost includes the original purchase price, costs directly attributable to bringing the asset to its working condition for its intended use, dismantling and restoration costs.

Land & buildings
Land and buildings include a Holiday Let owned by the company. Land and buildings are stated at cost (or deemed cost for land and buildings held at valuation at the date of transition to FRS 102) less accumulated depreciation and accumulated impairment losses.

Plant and machinery and fixtures, fittings, tools and equipment
Plant and machinery and fixtures, fittings, tools and equipment are stated at cost less accumulated depreciation and accumulated impairment losses.

Financial instruments
The Company only enters into basic financial instruments transactions that results in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non puttable ordinary shares.


BERKSHIRE BREAST SURGERY LIMITED (REGISTERED NUMBER: 07526846)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2025 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and
property machinery fittings
£    £    £   
COST
At 1 April 2025 454,925 25,936 253
Additions - - -
At 31 March 2026 454,925 25,936 253
DEPRECIATION
At 1 April 2025 - 22,474 253
Charge for year - 866 -
At 31 March 2026 - 23,340 253
NET BOOK VALUE
At 31 March 2026 454,925 2,596 -
At 31 March 2025 454,925 3,462 -

BERKSHIRE BREAST SURGERY LIMITED (REGISTERED NUMBER: 07526846)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

4. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£    £    £   
COST
At 1 April 2025 133,811 21,249 636,174
Additions - 799 799
At 31 March 2026 133,811 22,048 636,973
DEPRECIATION
At 1 April 2025 77,359 16,239 116,325
Charge for year 14,113 1,385 16,364
At 31 March 2026 91,472 17,624 132,689
NET BOOK VALUE
At 31 March 2026 42,339 4,424 504,284
At 31 March 2025 56,452 5,010 519,849

5. DEBTORS
2026 2025
£    £   
Amounts falling due within one year:
Trade debtors 26,794 14,384
Other debtors 380 400
Directors' current accounts 81,690 86,738
Prepayments and accrued income 19,522 17,285
128,386 118,807

Amounts falling due after more than one year:
Tax 45,049 44,353

Aggregate amounts 173,435 163,160

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Hire purchase contracts 1,186 4,739
Tax 35,302 33,834
Social security and other taxes - (574 )
Net wage control - 1,617
Credit card 19 113
Accrued expenses 3,500 3,500
40,007 43,229

BERKSHIRE BREAST SURGERY LIMITED (REGISTERED NUMBER: 07526846)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2026 2025
£    £   
Hire purchase contracts - 1,186

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2026 and 31 March 2025:

2026 2025
£    £   
Dr L K Smith
Balance outstanding at start of year 83,947 68,456
Amounts advanced 70,833 72,870
Amounts repaid (77,943 ) (57,379 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 76,837 83,947

Mr B M Smith
Balance outstanding at start of year 2,791 1,552
Amounts advanced 2,062 1,239
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 4,853 2,791

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
BERKSHIRE BREAST SURGERY LIMITED

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Berkshire Breast Surgery Limited for the year ended 31 March 2026 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Berkshire Breast Surgery Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Berkshire Breast Surgery Limited and state those matters that we have agreed to state to the Board of Directors of Berkshire Breast Surgery Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Berkshire Breast Surgery Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Berkshire Breast Surgery Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Berkshire Breast Surgery Limited. You consider that Berkshire Breast Surgery Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Berkshire Breast Surgery Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Dunhams
Chartered Accountants
11 Warwick Road
Old Trafford
Stretford
Manchester
M16 0QQ


5 August 2026